ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $79,000 | – | 15,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 1,105,139 | $3,072,000 | 6.35% |
| HARBERT FUND ADVISORS, INC. | 1,605,000 | $4,461,000 | 4.55% |
| Evermore Global Advisors, LLC | 4,527,819 | $12,587,000 | 2.06% |
| CORRADO ADVISORS, LLC | 223,783 | $622,000 | 0.61% |
| MARATHON CAPITAL MANAGEMENT | 332,046 | $923,000 | 0.46% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $265,000 | 0.18% |
| Alambic Investment Management, L.P. | 41,097 | $114,000 | 0.05% |
| ALGERT GLOBAL LLC | 58,171 | $162,000 | 0.04% |
| Trivium Point Advisory, LLC | 17,175 | $48,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 61,657 | $171,000 | 0.02% |